The FTSE 100 ended a difficult week firmly in negative territory on Friday, dragged lower by surging oil prices and growing unease over artificial intelligence investment returns. The blue-chip index closed down
The Delaware Court of Chancery has issued a sweeping opinion that is already being treated as essential reading for corporate law practitioners across the United States. The ruling emerged from a 100-plus
More
Veteran Supreme Court Justice Samuel Alito has made clear he has no intention of stepping down, pushing back firmly against mounting retirement pressure from fellow conservatives. Alito, who is 76 years old,
More
Deutsche Bank has raised its price target for Hikma Pharmaceuticals (LSE:HIK, OTC:HKMPF) to 2,050p from 1,950p, reiterating its buy rating on the FTSE 100 drugmaker. The upgrade follows a strong set of
More
The artificial intelligence boom has captured the imagination of markets, with billions of dollars pouring into the sector across every corner of the global economy. History offers sobering lessons about transformative technologies
More
President Donald Trump signed an executive order on August 10, 2026, titled “Delivering Gold Standard Childhood Vaccine Recommendations for Americans,” narrowing the recommended childhood vaccine list. The order reduces the number of
More
The U.S. Environmental Protection Agency has extended its Emerging Viral Pathogen Guidance for Antimicrobial Pesticides in response to the mpox virus, formerly known as monkeypox. The EPA originally developed its Emerging Viral
More
The legal industry is watching closely as big law firms edge toward private equity funding, raising questions about what that model truly means for the profession. The so-called management services structure, the
More
The FTSE 250 index has long been a hunting ground for acquirers seeking undervalued British businesses with strong fundamentals and growth potential. Merger and acquisition activity across UK mid-cap stocks has picked
More
Tenax Therapeutics (Nasdaq: TENX) has announced that its Phase 3 LEVEL clinical trial evaluating TNX-103, an oral form of levosimendan, failed to meet its primary endpoint. The trial, which enrolled 241 patients
More
The U.S. Department of Commerce’s Bureau of Industry and Security has issued a Temporary Final Rule placing sweeping new restrictions on the export of black mass and tungsten waste and scrap. The
More